Study identifies molecular mechanisms behind gestational diabetes progression

Te­va is the lat­est in a long list of drug­mak­ers plac­ing re­stric­tions around the fed­er­al 340B pro­gram which pro­vides dis­count­ed drugs for low-in­come Amer­i­cans. Ac­cord­ing

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.)  It’s of­fi­cial: Gen­er­al Cat­a­lyst is about to

The FDA on Tues­day grant­ed Mer­ck pri­or­i­ty re­view for its in­ves­ti­ga­tion­al pneu­mo­coc­cal vac­cine, mak­ing strides ahead of Pfiz­er in the com­pa­nies’ years­long con­test atop the